Synapse - Nursing

Results (55)

A randomized trial of prophylactic extended carboplatin infusion to reduce hypersensitivity reactions in recurrent ovarian cancer

Journal Article

LaVigne, K.; Hyman, D. M.; Zhou, Q. C.; Iasonos, A.; Tew, W. P.; Aghajanian, C.; Makker, V.; Hensley, M. L.; Konner, J.; Grisham, R. N.; more...
International Journal of Gynecological Cancer (2018)

Fulltext@MSK | Save

A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies

Meeting Abstract

Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors

Journal Article

Hyman, D. M.; Snyder, A. E.; Carvajal, R. D.; Gerecitano, J. F.; Voss, M. H.; Ho, A. L.; Konner, J.; Winkelmann, J. L.; Stasi, M. A.; Monson, K. R.; more...
Cancer Chemotherapy and Pharmacology (2015)

Fulltext@MSK | Save

Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer

Journal Article

Konner, J. A.; Grabon, D. M.; Gerst, S. R.; Iasonos, A.; Thaler, H.; Pezzulli, S. D.; Sabbatini, P. J.; Bell-Mcguinn, K. M.; Tew, W. P.; Hensley, M. L.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

CA125 response to bevacizumab in recurrent ovarian cancer

Meeting Abstract

O'Cearbhaill, R. E.; Zhou, Q.; Iasonos, A.; Diaz, J. P.; Tew, W. P.; Hensley, M. L.; O'Flaherty, C.; Aghajanian, C.; Spriggs, D. R.; Sabbatini, P.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors

Journal Article

Tew, W. P.; Gordon, M.; Murren, J.; Dupont, J.; Pezzulli, S.; Aghajanian, C.; Sabbatini, P.; Mendelson, D.; Schwartz, L.; Gettinger, S.; more...
Clinical Cancer Research (2010)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Final results of a phase I study of picoplatin and pegylated liposomal doxorubicin in advanced solid tumor malignancies

Meeting Abstract

Dizon, D. S.; Maluf, F.; Aghajanian, C. A.; Daud, A. I.; Sabbatini, P.; Pezzulli, S.; Soigne, S.; Spriggs, D. R.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission

Journal Article

Diefenbach, C. S. M.; Gnjatic, S.; Sabbatini, P.; Aghajanian, C.; Hensley, M. L.; Spriggs, D. R.; Iasonos, A.; Lee, H.; Dupont, B.; Pezzulli, S.; more...
Clinical Cancer Research (2008)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save